1例甲流患者抗感染治疗的病例分析
A Case Analysis of a Case of Influenza a Patient Undergoing Anti-Infection Treatment
DOI: 10.12677/acm.2025.1541281, PDF,    科研立项经费支持
作者: 李国花, 何 旭*, 王兴艳：大理白族自治州人民医院药剂科，云南 大理；杨媛君：大理白族自治州人民医院儿科，云南 大理；李同翠：大理白族自治州人民医院医用耗材采供部，云南 大理
关键词: 解甘露醇罗尔斯顿菌；抗感染治疗；病例分析；临床药师；Ralstonia mannitolilytica； Anti-Infective Treatment； Case Analysis； Clinical Pharmacists
摘要: 目的：介绍临床药师参与甲流患者抗感染会诊的病例，评价临床药师参与临床会诊案例的治疗效果。方法：介绍1例临床药师参与甲流患者抗感染治疗过程，紧扣痰培养检出的解甘露醇罗尔斯顿菌的判断和解读，从发热原因、病原菌的分析、病原菌的治疗选药、抗感染药物调整及疗效、用药监护等方面进行分析。结果：临床药师参与抗感染治疗方案制定取得明显的效果。结论：临床药师参与临床抗感染治疗方案的制定，对提高临床抗感染治疗的效果，确保抗感染药物的合理使用，起着极大的推动作用，体现出临床药师参与临床药物治疗的可行性和必要性。
Abstract: Objective: To introduce cases in which clinical pharmacists participated in anti-infection consultations in patients with influenza A, and evaluate the treatment effect of clinical pharmacists participating in clinical consultations. Methods: A clinical pharmacist who participated in the anti-infective treatment of a patient with influenza A was introduced. The judgment and interpretation of Ralstonia mannitolilytica detected in sputum culture were closely followed, and the causes of fever, analysis of pathogenic bacteria, selection of drugs for treatment of pathogenic bacteria, adjustment and efficacy of anti-infective drugs, and medication monitoring were analyzed. Results: Clinical pharmacists participated in the formulation of anti-infective treatment plans and achieved obvious results. Conclusion: Clinical pharmacists participation in the formulation of clinical anti-infective treatment plans plays a great role in improving the effectiveness of clinical anti-infective treatment and ensuring the rational use of anti-infective drugs, reflecting the feasibility and necessity of clinical pharmacists’ participation in clinical drug treatment.
文章引用：李国花, 何旭, 王兴艳, 杨媛君, 李同翠. 1例甲流患者抗感染治疗的病例分析[J]. 临床医学进展, 2025, 15(4): 3148-3155. https://doi.org/10.12677/acm.2025.1541281

参考文献

[1] 吴艳艳, 申瑶, 何全利, 等. 57例甲型流感病毒感染合并肺炎患者感染指标与病毒载量相关性[J]. 中国感染控制杂志, 2021, 20(4): 357-360.
[2] 中华医学会呼吸病学分会. 中国成人社区获得性肺炎诊断和治疗指南(2016年版) [J]. 中华结核和呼吸杂志, 2016, 39(4): 253-279.
[3] 中华医学会呼吸病学分会中华医学会儿科学分会. 流行性感冒抗病毒药物治疗与预防应用中国专家共识[J]. 浙江医学, 2016, 38(5): 305-310.
[4] Vardakas, K.Z., Matthaiou, D.K. and Falagas, M.E. (2009) Incidence, Characteristics and Outcomes of Patients with Severe Community Acquired-Mrsa Pneumonia. European Respiratory Journal, 34, 1148-1158. [Google Scholar] [CrossRef] [PubMed]
[5] 李洪涛, 张天托, 黄静, 等. 社区获得性耐甲氧西林金黄色葡萄球菌肺炎死亡相关危险因素分析[1]. 中国危重病急救医学, 2010, 22(8): 459-464.
[6] Gillet, Y., Issartel, B., Vanhems, P., Fournet, J., Lina, G., Bes, M., et al. (2002) Association between Staphylococcus aureus Strains Carrying Gene for Panton-Valentine Leukocidin and Highly Lethal Necrotising Pneumonia in Young Immunocompetent Patients. The Lancet, 359, 753-759. [Google Scholar] [CrossRef] [PubMed]
[7] Mandell, L.A., Wunderink, R.G., Anzueto, A., Bartlett, J.G., Campbell, G.D., Dean, N.C., et al. (2007) Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases, 44, S27-S72. [Google Scholar] [CrossRef] [PubMed]
[8] Wunderink, R.G. (2013) How Important Is Methicillin-Resistant Staphylococcus aureus as a Cause of Community-Acquired Pneumonia and What Is Best Antimicrobial Therapy? Infectious Disease Clinics of North America, 27, 177-188. [Google Scholar] [CrossRef] [PubMed]
[9] 袁凤丽. 解甘露醇罗尔斯顿菌的研究进展[J]. 临床医药实践, 2019, 28(6): 456-459.
[10] De Baere, T., Steyaert, S., Wauters, G., Des Vos, P., Goris, J., Coenye, T., et al. (2001) Classification of Ralstonia pickettii Biovar 3/ “thomasii” Strains (Pickett 1994) and of New Isolates Related to Nosocomial Recurrent Meningitis as Ralstonia mannitolilytica sp. nov. International Journal of Systematic and Evolutionary Microbiology, 51, 547-558. [Google Scholar] [CrossRef] [PubMed]
[11] Kim, G., Yoo, R.N., So, H., Lee, J., Kim, M., Kim, S., et al. (2023) Clinical Manifestation of Ralstonia mannitolilytica Infection in Pediatric Patients and Epidemiological Investigation of Outbreaks. Journal of Korean Medical Science, 38, e252. [Google Scholar] [CrossRef] [PubMed]
[12] 张亚宁, 孙光伟. 颈椎后路单开门椎管扩大椎板成形术后感染解甘露醇罗尔斯顿菌1例报告并文献复习[J]. 脊柱外科杂志, 2021, 19(5): 358-360.
[13] 葛玉梅, 陈学波, 黄燕颖, 等. 解甘露醇罗尔斯顿菌的耐药性和原卟啉亚铁螯合酶毒力因子研究[J]. 浙江大学学报(医学版), 2017, 46(4): 413-420.
[14] 寿晓岚, 胡玮琳, 邵泓瑜, 等. 一例败血症患者解甘露醇罗尔斯顿菌的分离与鉴定及其耐药相关基因分析[J]. 中华微生物学和免疫学杂志, 2016, 36(1): 57-63.
[15] Daxboeck, F., Stadler, M., Assadian, O., Marko, E., Hirschl, A.M. and Koller, W. (2005) Characterization of Clinically Isolated Ralstonia mannitolilytica Strains Using Random Amplification of Polymorphic DNA (RAPD) Typing and Antimicrobial Sensitivity, and Comparison of the Classification Efficacy of Phenotypic and Genotypic Assays. Journal of Medical Microbiology, 54, 55-61. [Google Scholar] [CrossRef] [PubMed]
[16] Papagrigorakis, E., Vavourakis, M., Vlachos, C., Zachariou, D., Galanis, A., Marougklianis, V., et al. (2022) Osteomyelitis Caused by Ralstonia mannitolilytica, a Rare Opportunistic Pathogen. Cureus, 14, e24151. [Google Scholar] [CrossRef] [PubMed]
[17] Frampton, J.E. and Curran, M.P. (2005) Tigecycline. Drugs, 65, 2623-2635. [Google Scholar] [CrossRef] [PubMed]
[18] Yaghoubi, S., Zekiy, A.O., Krutova, M., Gholami, M., Kouhsari, E., Sholeh, M., et al. (2021) Tigecycline Antibacterial Activity, Clinical Effectiveness, and Mechanisms and Epidemiology of Resistance: Narrative Review. European Journal of Clinical Microbiology & Infectious Diseases, 41, 1003-1022. [Google Scholar] [CrossRef] [PubMed]

为你推荐